Skip to main content
Top
Published in: Cancer Imaging 1/2024

Open Access 01-12-2024 | Metastasis | Research article

Predicting occult lymph node metastasis in solid-predominantly invasive lung adenocarcinoma across multiple centers using radiomics-deep learning fusion model

Authors: Weiwei Tian, Qinqin Yan, Xinyu Huang, Rui Feng, Fei Shan, Daoying Geng, Zhiyong Zhang

Published in: Cancer Imaging | Issue 1/2024

Login to get access

Abstract

Background

In solid-predominantly invasive lung adenocarcinoma (SPILAC), occult lymph node metastasis (OLNM) is pivotal for determining treatment strategies. This study seeks to develop and validate a fusion model combining radiomics and deep learning to predict OLNM preoperatively in SPILAC patients across multiple centers.

Methods

In this study, 1325 cT1a-bN0M0 SPILAC patients from six hospitals were retrospectively analyzed and divided into pathological nodal positive (pN+) and negative (pN-) groups. Three predictive models for OLNM were developed: a radiomics model employing decision trees and support vector machines; a deep learning model using ResNet-18, ResNet-34, ResNet-50, DenseNet-121, and Swin Transformer, initialized randomly or pre-trained on large-scale medical data; and a fusion model integrating both approaches using addition and concatenation techniques. The model performance was evaluated by the area under the receiver operating characteristic (ROC) curve (AUC).

Results

All patients were assigned to four groups: training set (n = 470), internal validation set (n = 202), and independent test set 1 (n = 227) and 2 (n = 426). Among the 1325 patients, 478 (36%) had OLNM (pN+). The fusion model, combining radiomics with pre-trained ResNet-18 features via concatenation, outperformed others with an average AUC (aAUC) of 0.754 across validation and test sets, compared to aAUCs of 0.715 for the radiomics model and 0.676 for the deep learning model.

Conclusion

The radiomics-deep learning fusion model showed promising ability to generalize in predicting OLNM from CT scans, potentially aiding personalized treatment for SPILAC patients across multiple centers.
Appendix
Available only for authorised users
Literature
1.
go back to reference Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17–48.CrossRefPubMed Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17–48.CrossRefPubMed
2.
go back to reference Hung J-J, Jeng W-J, Chou T-Y, Hsu W-H, Wu K-J, Huang B-S, et al. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification on death and recurrence in completely resected stage I lung adenocarcinoma. Ann Surg. 2013;258:1079–86.CrossRefPubMed Hung J-J, Jeng W-J, Chou T-Y, Hsu W-H, Wu K-J, Huang B-S, et al. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification on death and recurrence in completely resected stage I lung adenocarcinoma. Ann Surg. 2013;258:1079–86.CrossRefPubMed
3.
go back to reference Hung J-J, Yeh Y-C, Jeng W-J, Wu K-J, Huang B-S, Wu Y-C, et al. Predictive value of the international association for the study of lung cancer/American Thoracic Society/European Respiratory Society classification of lung adenocarcinoma in tumor recurrence and patient survival. J Clin Oncol. 2014;32:2357–64.CrossRefPubMed Hung J-J, Yeh Y-C, Jeng W-J, Wu K-J, Huang B-S, Wu Y-C, et al. Predictive value of the international association for the study of lung cancer/American Thoracic Society/European Respiratory Society classification of lung adenocarcinoma in tumor recurrence and patient survival. J Clin Oncol. 2014;32:2357–64.CrossRefPubMed
4.
go back to reference Hung J-J, Yeh Y-C, Jeng W-J, Wu Y-C, Chou T-Y, Hsu W-H. Factors predicting occult lymph node metastasis in completely resected lung adenocarcinoma of 3 cm or smaller. Eur J Cardiothorac Surg. 2016;50:329–36.CrossRefPubMed Hung J-J, Yeh Y-C, Jeng W-J, Wu Y-C, Chou T-Y, Hsu W-H. Factors predicting occult lymph node metastasis in completely resected lung adenocarcinoma of 3 cm or smaller. Eur J Cardiothorac Surg. 2016;50:329–36.CrossRefPubMed
5.
go back to reference Moon Y, Kim KS, Lee KY, Sung SW, Kim YK, Park JK. Clinicopathologic factors associated with occult lymph node metastasis in patients with clinically diagnosed N0 lung adenocarcinoma. Ann Thorac Surg. 2016;101:1928–35.CrossRefPubMed Moon Y, Kim KS, Lee KY, Sung SW, Kim YK, Park JK. Clinicopathologic factors associated with occult lymph node metastasis in patients with clinically diagnosed N0 lung adenocarcinoma. Ann Thorac Surg. 2016;101:1928–35.CrossRefPubMed
6.
go back to reference Nakamura K, Saji H, Nakajima R, Okada M, Asamura H, Shibata T, et al. A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L). Jpn J Clin Oncol. 2010;40:271–4.CrossRefPubMed Nakamura K, Saji H, Nakajima R, Okada M, Asamura H, Shibata T, et al. A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L). Jpn J Clin Oncol. 2010;40:271–4.CrossRefPubMed
7.
go back to reference Postmus PE, Kerr KM, Oudkerk M, Senan S, Waller DA, Vansteenkiste J, et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28:iv1–21.CrossRefPubMed Postmus PE, Kerr KM, Oudkerk M, Senan S, Waller DA, Vansteenkiste J, et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28:iv1–21.CrossRefPubMed
8.
go back to reference Prabhakar B, Shende P, Augustine S. Current trends and emerging diagnostic techniques for lung cancer. Biomed Pharmacother. 2018;106:1586–99.CrossRefPubMed Prabhakar B, Shende P, Augustine S. Current trends and emerging diagnostic techniques for lung cancer. Biomed Pharmacother. 2018;106:1586–99.CrossRefPubMed
9.
go back to reference Pak K, Park S, Cheon GJ, Kang KW, Kim I-J, Lee DS, et al. Update on nodal staging in non-small cell lung cancer with integrated positron emission tomography/computed tomography: a meta-analysis. Ann Nucl Med. 2015;29:409–19.CrossRefPubMed Pak K, Park S, Cheon GJ, Kang KW, Kim I-J, Lee DS, et al. Update on nodal staging in non-small cell lung cancer with integrated positron emission tomography/computed tomography: a meta-analysis. Ann Nucl Med. 2015;29:409–19.CrossRefPubMed
10.
go back to reference Seol HY, Kim YS, Kim S-J. Predictive value of 18F-fluorodeoxyglucose positron emission tomography or positron emission tomography/computed tomography for assessment of occult lymph node metastasis in non-small cell lung cancer. Oncology. 2021;99:96–104.CrossRefPubMed Seol HY, Kim YS, Kim S-J. Predictive value of 18F-fluorodeoxyglucose positron emission tomography or positron emission tomography/computed tomography for assessment of occult lymph node metastasis in non-small cell lung cancer. Oncology. 2021;99:96–104.CrossRefPubMed
11.
go back to reference Kandathil A, Kay FU, Butt YM, Wachsmann JW, Subramaniam RM. Role of FDG PET/CT in the eighth edition of TNM staging of non-small cell lung cancer. Radiographics. 2018;38:2134–49.CrossRefPubMed Kandathil A, Kay FU, Butt YM, Wachsmann JW, Subramaniam RM. Role of FDG PET/CT in the eighth edition of TNM staging of non-small cell lung cancer. Radiographics. 2018;38:2134–49.CrossRefPubMed
12.
go back to reference He L, Huang Y, Yan L, Zheng J, Liang C, Liu Z. Radiomics-based predictive risk score: a scoring system for preoperatively predicting risk of lymph node metastasis in patients with resectable non-small cell lung cancer. Chin J Cancer Res. 2019;31:641–52.CrossRefPubMedPubMedCentral He L, Huang Y, Yan L, Zheng J, Liang C, Liu Z. Radiomics-based predictive risk score: a scoring system for preoperatively predicting risk of lymph node metastasis in patients with resectable non-small cell lung cancer. Chin J Cancer Res. 2019;31:641–52.CrossRefPubMedPubMedCentral
13.
go back to reference Cong M, Feng H, Ren J-L, Xu Q, Cong L, Hou Z, et al. Development of a predictive radiomics model for lymph node metastases in pre-surgical CT-based stage IA non-small cell lung cancer. Lung Cancer. 2020;139:73–9.CrossRefPubMed Cong M, Feng H, Ren J-L, Xu Q, Cong L, Hou Z, et al. Development of a predictive radiomics model for lymph node metastases in pre-surgical CT-based stage IA non-small cell lung cancer. Lung Cancer. 2020;139:73–9.CrossRefPubMed
14.
go back to reference Gu J, Wang Z, Kuen J, Ma L, Shahroudy A, Shuai B, et al. Recent advances in convolutional neural networks. Pattern Recognit. 2018;77:354–77.CrossRef Gu J, Wang Z, Kuen J, Ma L, Shahroudy A, Shuai B, et al. Recent advances in convolutional neural networks. Pattern Recognit. 2018;77:354–77.CrossRef
15.
go back to reference Vaswani A, Shazeer N, Parmar N, Uszkoreit J, Jones L, Gomez AN, et al. Attention is all you need. In: Proceedings of the 31st International Conference on Neural Information Processing Systems. 2017. p. 6000–6010. Vaswani A, Shazeer N, Parmar N, Uszkoreit J, Jones L, Gomez AN, et al. Attention is all you need. In: Proceedings of the 31st International Conference on Neural Information Processing Systems. 2017. p. 6000–6010.
16.
go back to reference Wang Y-W, Chen C-J, Huang H-C, Wang T-C, Chen H-M, Shih J-Y, et al. Dual energy CT image prediction on primary tumor of lung cancer for nodal metastasis using deep learning. Comput Med Imaging Graph. 2021;91:101935.CrossRefPubMed Wang Y-W, Chen C-J, Huang H-C, Wang T-C, Chen H-M, Shih J-Y, et al. Dual energy CT image prediction on primary tumor of lung cancer for nodal metastasis using deep learning. Comput Med Imaging Graph. 2021;91:101935.CrossRefPubMed
17.
go back to reference Ma X, Xia L, Chen J, Wan W, Zhou W. Development and validation of a deep learning signature for predicting lymph node metastasis in lung adenocarcinoma: comparison with radiomics signature and clinical-semantic model. Eur Radiol. 2023;33:1949–62.CrossRefPubMed Ma X, Xia L, Chen J, Wan W, Zhou W. Development and validation of a deep learning signature for predicting lymph node metastasis in lung adenocarcinoma: comparison with radiomics signature and clinical-semantic model. Eur Radiol. 2023;33:1949–62.CrossRefPubMed
18.
go back to reference He K, Zhang X, Ren S, Sun J. Deep residual learning for image recognition. In: Proceedings of the IEEE/CVF conference on computer vision and pattern recognition. 2016. p. 770–778. He K, Zhang X, Ren S, Sun J. Deep residual learning for image recognition. In: Proceedings of the IEEE/CVF conference on computer vision and pattern recognition. 2016. p. 770–778.
19.
go back to reference Huang G, Liu Z, Maaten L van der, Weinberger KQ. Densely connected convolutional networks. In: Proceedings of the IEEE/CVF conference on computer vision and pattern recognition. 2017. p. 4700–4708. Huang G, Liu Z, Maaten L van der, Weinberger KQ. Densely connected convolutional networks. In: Proceedings of the IEEE/CVF conference on computer vision and pattern recognition. 2017. p. 4700–4708.
20.
go back to reference Liu Z, Lin Y, Cao Y, Hu H, Wei Y, Zhang Z, et al. Swin transformer: hierarchical vision transformer using shifted windows. In: Proceedings of the IEEE/CVF international conference on computer vision. 2021. p. 10012–10022. Liu Z, Lin Y, Cao Y, Hu H, Wei Y, Zhang Z, et al. Swin transformer: hierarchical vision transformer using shifted windows. In: Proceedings of the IEEE/CVF international conference on computer vision. 2021. p. 10012–10022.
21.
go back to reference Chen S, Ma K, Zheng Y. Med3d: transfer learning for 3d medical image analysis. arXiv preprint arXiv. 2019:1904.00625. Chen S, Ma K, Zheng Y. Med3d: transfer learning for 3d medical image analysis. arXiv preprint arXiv. 2019:1904.00625.
22.
go back to reference Tang Y, Yang D, Li W, Roth HR, Landman B, Xu D, et al. Self-supervised pre-training of swin transformers for 3d medical image analysis. In: Proceedings of the IEEE/CVF conference on computer vision and pattern recognition. 2022. p. 20730–20740. Tang Y, Yang D, Li W, Roth HR, Landman B, Xu D, et al. Self-supervised pre-training of swin transformers for 3d medical image analysis. In: Proceedings of the IEEE/CVF conference on computer vision and pattern recognition. 2022. p. 20730–20740.
23.
go back to reference Wang Z, Liu Q, Dou Q. Contrastive cross-site learning with redesigned net for COVID-19 CT classification. IEEE J Biomed Health Inform. 2020;24:2806–13.CrossRefPubMed Wang Z, Liu Q, Dou Q. Contrastive cross-site learning with redesigned net for COVID-19 CT classification. IEEE J Biomed Health Inform. 2020;24:2806–13.CrossRefPubMed
24.
go back to reference He K, Fan H, Wu Y, Xie S, Girshick R. Momentum contrast for unsupervised visual representation learning. In: Proceedings of the IEEE/CVF conference on computer vision and pattern recognition. 2020. p. 9729–9738. He K, Fan H, Wu Y, Xie S, Girshick R. Momentum contrast for unsupervised visual representation learning. In: Proceedings of the IEEE/CVF conference on computer vision and pattern recognition. 2020. p. 9729–9738.
Metadata
Title
Predicting occult lymph node metastasis in solid-predominantly invasive lung adenocarcinoma across multiple centers using radiomics-deep learning fusion model
Authors
Weiwei Tian
Qinqin Yan
Xinyu Huang
Rui Feng
Fei Shan
Daoying Geng
Zhiyong Zhang
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Cancer Imaging / Issue 1/2024
Electronic ISSN: 1470-7330
DOI
https://doi.org/10.1186/s40644-024-00654-2

Other articles of this Issue 1/2024

Cancer Imaging 1/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine